Natural Killer Cells Therapies

1
Natural Killer Cells Therapies
2
Summary

• Natural Killer Cells Therapies- Competitive
  Landscape, Technology and Pipeline Analysis,
  2017, emphasizes on the currently active NK cell
  therapy products and NK cell augmenters in
  research and development.
• The report covers 20 companies, which are active
  in this field with 40 products and many
  different technologies. This report covers NK
  cell based therapies and drugs that augment
  (enhance or activate) the NK cells. The report
  provides in-depth analysis on the Natural Killer
  Cell based therapies profiles along with the
  augmenting therapies covering their pre-clinical
  and clinical studies, collaborations details and
  deal values, technologies and targeted antigens.
  The report provides the NK Cell based therapies
  licensing opportunities, acquisitions, market
  drivers and barriers followed by SWOT Analysis.

3
(No Transcript)
4

• Reports Highlights
• - NK cell Therapy Pipeline scenario which
  includes NK cell therapies and NK cell augmenting
  therapies.
• - Collaborations partnering deals
• - Current Prominent Research Areas and Key
  Players
• - Pipeline product profiles NK Cell therapy
  Technologies and NK cell Augmenting Therapies
• - Licensing opportunities
• - Market Drivers and Barriers

5
Scope

• Overview of the global NK cell therapy and NK
  cell augmenting therapies pipeline scenario,
  products and associated companies information
• Coverage of global NK cell therapies and drugs
  that enhance the activity of NK under development
• Competitive landscape of products for key
  players and related indications
• Coverage of licensors, collaborators and
  development partners, deal terms and deal values
  estimation
• Pipeline analysis across different phases,
  emerging trends and comparative analysis of
  pipeline products with detailed clinical
  profiles, mechanism of action, route of
  administration and molecule type, along with
  product development activities
• Highlights of licensing collaboration
  opportunities and funding details
• Highlights of latest NK cell therapy
  technologies and NK cell augmenting therapies and
  innovative companies
• Key topics covered include strategic competitor
  assessment, barriers and drivers in the market
  along with SWOT analysis

6
Table of Contents

• Executive Summary
• Market Barriers
• Natural Killer Cells Based Therapies and Targets
• Collaborations and Deal value
• Pipeline Therapeutics for Natural Killer Cells
  Based Therapies
• Comparative Analysis
• Therapeutic Assessment of Natural Killer Cell
  Therapies
• Assessment by Stage and Route of Administration
• Targets of Natural Killer Cells Augmenters and
  Their Analysis
• Companies received Grants for NK cells
  augmenters based therapies
• Pipeline Therapeutics for Natural Killer Cells
  Augmenters(Enhancers Activators)
• Therapeutic Assessment of Natural Killer Cell
  Augmenters (Enhancers Activators)
• Appendix

7
Full Reports
Natural Killer Cells Therapies
Contact us atBharat Book Bureau Tel 91 22
27810772 / 27810773 Emailpoonam_at_bharatbook.com Ou
r Bloghttps//www.bharatbook.com/blog/ Twitterht
tps//twitter.com/researchbook Facebookhttps//ww
w.facebook.com/BharatBook3B LinkedInhttp//www.li
nkedin.com/company/bharat-book-bureau
8
THANK YOU